MKS Instruments Inc.'s recent activity presents a blend of insider selling coupled with positive quarterly financial disclosures. Specifically, Jacqueline F Moloney, who serves as a director at MKS INC (NASDAQ:MKSI), conducted a transaction involving the sale of company stock.
On May 13, 2026, Ms. Moloney sold 1,400 shares of MKS INC's common stock. The sale was executed at a price point of $318.99 per share, resulting in a total proceeds of $446,586. Following this transaction, the director's direct holdings in MKS INC common stock were reported as 9,775.156 shares.
The timing of this sale is notable given the recent performance context for MKSI stock. The equity has been trading near its 52-week high of $326.83, following a substantial gain of 240% over the past year. Currently, the stock trades at $312.61. However, an analysis from InvestingPro suggests that the company may be overvalued when compared against its calculated Fair Value.
Beyond the insider trading activity, MKS Instruments Inc. provided robust financial results for the first quarter of 2026. These disclosures exceeded market expectations on multiple fronts, signaling strong operational momentum within the organization.
For Q1 2026, MKS Instruments reported an earnings per share (EPS) of $2.30. This figure surpassed the anticipated EPS of $2.04, representing a significant earnings surprise of 12.75%. Furthermore, the company announced total revenue of $1.08 billion. This amount also exceeded the expected revenue of $1.05 billion, generating a 2.86% revenue surprise.
These combined results underscore MKS Instruments' strong performance during the quarter. While the provided information did not detail specific analyst upgrades or downgrades, the positive nature of the earnings report suggests an overall favorable view among market observers regarding the company's trajectory. These developments contribute to the latest updates concerning MKS Instruments.
Investors interested in a deeper understanding of MKSI’s valuation and comprehensive analysis have access to detailed Pro Research Reports. This resource provides insights into valuation for MKSI and over 1,400 other US equities.
The market data presented shows the current trading price at $312.64, indicating a slight decrease of -4.67 or -1.47% from previous readings.